Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00375518
Other study ID # 06-079
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 2006
Est. completion date May 2014

Study information

Verified date December 2020
Source Memorial Sloan Kettering Cancer Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will compare atorvastatin (Lipitor) with a placebo (inactive pill) to see if this drug reduces heart rhythm abnormalities (arrhythmias) or lung inflammation after thoracic surgery. Preliminary results suggest that cholesterol lowering drugs (statins) may reduce problems after surgery such as arrhythmias or lung inflammation which may be serious. This study will be randomized and double blind, meaning that patients are placed in groups purely by chance, like flipping a coin. Neither the patient or doctor will know which group the patient is in.


Description:

Hypothesis: Statins attenuate perioperative inflammatory and oxidative mechanisms that contribute to the initiation and severity of cardiopulmonary complications after thoracic surgery. Aim 1. To determine whether prophylactic administration of atorvastatin attenuates the inflammatory and oxidative response to surgery and significantly reduces the composite risk of cardiovascular morbidity (atrial fibrillation (AF), acute coronary syndrome, myocardial infarction (MI), cerebrovascular accident (CVA), pulmonary embolism) and mortality within 30 days after thoracic surgery. Aim 2. To explore whether prophylactic administration of atorvastatin attenuates the inflammatory and oxidative (CRP, IL-6, TNF, and MPO) response to surgery and significantly reduces the overall risk of pulmonary complications (atelectasis, pneumonia, pneumonitis, acute respiratory failure) after thoracic surgery. Aim 3. To explore the association of single nucleotide polymorphism (SNP) changes in genes linked to atrial fibrillation and inflammatory markers and development of pulmonary morbidity after thoracic surgery. Aim 4. To explore whether an imbalance between metalloproteinase (MMP)-1 and its inhibitor (TIMP) is associated with postoperative atrial fibrillation risk and/or development of pulmonary morbidity after thoracic surgery.


Recruitment information / eligibility

Status Completed
Enrollment 162
Est. completion date May 2014
Est. primary completion date May 2014
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult patients = 18 yr. scheduled for anatomic lung resection (segmentectomy, lingulectomy, possible or definite lobectomy, bilobectomy, pneumonectomy or extrapleural pneumonectomy) with or without chest wall resection or limited resection - Patients with regular cardiac rhythm - Patients able to take oral capsules - Patients capable of providing written, informed consent - Patients without known hepatic or kidney disease Exclusion Criteria: - Patients already taking any statin, gemfibrozil (Lopid), or ezetimibe (Zetia) - Hypersensitivity to atorvastatin - Chronic atrial fibrillation - Patients already taking class Ic or III antiarrhythmic drugs - Known pregnancy a urine pregnancy test will be given to women of childbearing age - Known history of active hepatic disease or known hepatic insufficiency - Known history of active kidney disease or insufficiency

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Atorvastatin
Atorvastatin 40 mg once a day beginning 7 days before the operation. Surgical procedures will be as planned and unaffected by this study. Starting from the day after surgery, patients will be given their study drug for an additional 7 days.
Placebo
Placebo given beginning 7 days before the operation. Starting from the day after surgery, patients will be given their study drug for an additional 7 days.

Locations

Country Name City State
United States Memorial Sloan-Kettering Cancer Center 1275 York Avenue New York New York

Sponsors (1)

Lead Sponsor Collaborator
Memorial Sloan Kettering Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Determine the Postoperative Complications Found in Each Group To determine whether one week of preventive therapy with atorvastatin prior to surgery and one week after surgery reduced the composite rate of cardiovascular morbidity when compared to placebo. one week (minimum of 5 days) before surgery and continued for one week (minimum of 5 days) after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT04865874 - GDT-PPV Protocol in Thoracic Surgery N/A
Active, not recruiting NCT02715271 - Study of TB Lesions Obtained in Therapeutical Surgery
Completed NCT02919267 - Physiology of Lung Collapse Under One-Lung Ventilation: Underlying Mechanisms N/A
Completed NCT02964026 - Study of Clinical Outcomes Associated With the Pulmonary Artery Catheter (PAC) in Cardiac Surgery Patients N/A
Recruiting NCT03165539 - Cerebral Oxygen Desaturation and Post-Operative Delirium in Thoracic Surgical Patients
Terminated NCT01320475 - Epidural Levobupivacaine-sufentanil Versus Epidural Levobupivacaine and Intravenous Ketamine Phase 4
Recruiting NCT05045196 - Health-promoting Family Conversations and Open Heart Surgery N/A
Completed NCT04507958 - Electronic Stethoscope Use During Intubation in Full Personal Protective Equipment
Recruiting NCT05060302 - Prognosis of Right Ventricular Dysfunction Assessed by Speckle Tracking in Postoperative Thoracic Surgery N/A
Completed NCT05667467 - The Effect of Care Bundle in Heart Surgery N/A
Not yet recruiting NCT03275428 - THRIVE and Non-intubated Thoracic Surgery N/A
Not yet recruiting NCT05482230 - Application of Tracheal Intubation in Lateral Position in Thoracic Surgery N/A
Enrolling by invitation NCT04429009 - A Randomized Control Trial of ZEPHYRx Gamified Incentive Spirometry Compared to Traditional Spirometry N/A
Not yet recruiting NCT03628040 - Erector Spinae Plane Block for Video-assisted Thoracoscopic Surgery Phase 3
Recruiting NCT03300622 - Assessment in Patients After Thoracic Surgery N/A
Completed NCT00981474 - Cerebral Autoregulation Monitoring During Cardiac Surgery N/A
Completed NCT03309280 - Influence of Different Parameters on Extubation Time After Cardiac Surgery.
Recruiting NCT03820700 - Using Hypnosis and Virtual Reality During Pre and Postoperative Cardiovascular Surgery. N/A
Completed NCT03768193 - Deep Serratus Anterior Plane Block vs Surgically-placed Paravertebral Block for VATS Surgery N/A
Recruiting NCT04609228 - Cardiac Surgery Outcomes in Blood-transfusion Acceptors and no Acceptors